Dr. Coylewright is funded research scientist, mentor, and leader in interventional cardiology, serving as Director of the Structural Heart Program at The Erlanger Heart and Lung Institute in Chattanooga, TN. Previously, Dr. Coylewright founded the transcatheter mitral and tricuspid valve repair and left atrial appendage closure programs at Dartmouth, where she was promoted to Associate Professor.
Dr. Coylewright serves as the PI for multiple trials focused on structural heart disease, and is on the global steering committee for CHAMPION AF, a large study comparing DOACs to watchman for stroke prevention. Additionally, her research focuses on diversity, equity and inclusion, complimenting her role as Vice Chief of Cardiology for Faculty Development within southern Tennessee's only academic cardiovascular program.
As a frequent lecturer on structural heart topics, health policy, and shared decision making, Dr. Coylewright serves on the planning committees for the Scientific Sessions of ACC, TCT and SCAI. She contributes to multiple national guideline writing committees on technical topics and professionalism and ethics. She was selected for the Emerging Leader Mentorship Program of SCAI and the Emerging Faculty program for ACC.
Dr. Coylewright completed her medical school, residency, and Master of Public Health training at Johns Hopkins in Baltimore. Five years of cardiovascular training were spent at the Mayo Clinic in her home state of Minnesota, finishing with an Advanced Interventional Cardiology fellowship in Structural Heart Disease.